What is Intas?
Founded in 1976 and headquartered in Ahmedabad, Gujarat, India, Intas has evolved into a vertically integrated pharmaceutical powerhouse. The company specializes in the end-to-end manufacturing and research of high-quality pharmaceutical products, serving both domestic and international markets. Its operational model is characterized by a robust commitment to innovation, rigorous quality control, and a diverse portfolio that spans various therapeutic categories. As an enterprise-level entity, Intas maintains a sophisticated infrastructure that supports large-scale production while simultaneously driving advancements in drug delivery systems and biosimilars, positioning it as a critical player in the global healthcare supply chain.
How much funding has Intas raised?
Intas has raised a total of $106.3M across 1 funding round:
Other Financing Round
$106.3M
Other Financing Round (2017): $106.3M with participation from Capital Group
Key Investors in Intas
Capital Group
A global investment management firm known for its long-term perspective and significant participation in large-scale enterprise financing rounds.
What's next for Intas?
With the recent infusion of capital, Intas is well-positioned to accelerate its strategic initiatives, particularly in the realms of global market expansion and advanced pharmaceutical research. The company is expected to prioritize the scaling of its manufacturing capabilities to meet the rising demand for specialized therapeutics. Furthermore, this financial backing provides the necessary liquidity to explore potential inorganic growth opportunities, such as strategic partnerships or acquisitions that align with its long-term vision of enhancing patient outcomes through scientific excellence. As the firm navigates the complexities of the modern regulatory environment, this investment serves as a catalyst for maintaining its competitive edge and operational efficiency.
See full Intas company page
